Yichen Zhong

609 total citations · 1 hit paper
12 papers, 335 citations indexed

About

Yichen Zhong is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Yichen Zhong has authored 12 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Immunology and 2 papers in Infectious Diseases. Recurrent topics in Yichen Zhong's work include RNA Interference and Gene Delivery (5 papers), Immunotherapy and Immune Responses (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Yichen Zhong is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), Immunotherapy and Immune Responses (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Yichen Zhong collaborates with scholars based in United States. Yichen Zhong's co-authors include Shi Du, Yonger Xue, Yizhou Dong, Jinyue Yan, Xucheng Hou, Diana D. Kang, Binbin Deng, David W. McComb, Chang Wang and Yuebao Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Yichen Zhong

11 papers receiving 331 citations

Hit Papers

LNP-RNA-engineered adipose stem cells for accelerated dia... 2024 2026 2025 2024 10 20 30 40

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yichen Zhong United States 7 198 116 67 54 44 12 335
Vinod Nadella India 12 158 0.8× 222 1.9× 41 0.6× 101 1.9× 40 0.9× 16 471
Connie Qiu United States 8 117 0.6× 81 0.7× 48 0.7× 53 1.0× 25 0.6× 14 369
Rashin Mohseni Iran 8 196 1.0× 107 0.9× 42 0.6× 39 0.7× 26 0.6× 31 329
Hye‐Nam Son South Korea 12 152 0.8× 46 0.4× 52 0.8× 32 0.6× 50 1.1× 14 346
Cinnamon L Hardee United States 7 275 1.4× 109 0.9× 53 0.8× 137 2.5× 27 0.6× 10 438
Rafieh Bagherifar Iran 6 247 1.2× 59 0.5× 47 0.7× 38 0.7× 46 1.0× 7 325
Yael Diesendruck Israel 9 244 1.2× 120 1.0× 67 1.0× 72 1.3× 69 1.6× 13 464
Maria Cecília Zorél Meneghetti Brazil 8 170 0.9× 28 0.2× 29 0.4× 32 0.6× 29 0.7× 13 396
Muhammad Moazzam Pakistan 5 260 1.3× 38 0.3× 56 0.8× 24 0.4× 40 0.9× 13 355

Countries citing papers authored by Yichen Zhong

Since Specialization
Citations

This map shows the geographic impact of Yichen Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yichen Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yichen Zhong more than expected).

Fields of papers citing papers by Yichen Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yichen Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yichen Zhong. The network helps show where Yichen Zhong may publish in the future.

Co-authorship network of co-authors of Yichen Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Yichen Zhong. A scholar is included among the top collaborators of Yichen Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yichen Zhong. Yichen Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Cao, Dinglingge, Xucheng Hou, Chang Wang, et al.. (2025). Lipid nanoparticles for mRNA delivery in brain via systemic administration. Science Advances. 11(33). eadw0730–eadw0730. 2 indexed citations
3.
Hou, Xucheng, Chang Wang, Yichen Zhong, et al.. (2025). Enhancing antitumor immunity through chemotherapeutic-derived lipid nanoparticle-induced immunogenic cell death and CD40L/Flt3L mRNA-mediated dendritic cell activation. Journal of Controlled Release. 382. 113684–113684. 1 indexed citations
4.
Lin, Mingqun, Qi Yan, Khemraj Budachetri, et al.. (2024). Development of Etf-3-specific nanobodies to prevent Ehrlichia infection and LNP-mRNA delivery in cellular and murine models. Microbiological Research. 292. 128027–128027. 1 indexed citations
5.
Kang, Diana D., Xucheng Hou, Leiming Wang, et al.. (2024). Engineering LNPs with polysarcosine lipids for mRNA delivery. Bioactive Materials. 37. 86–93. 36 indexed citations
6.
Xue, Yonger, Yuebao Zhang, Yichen Zhong, et al.. (2024). LNP-RNA-engineered adipose stem cells for accelerated diabetic wound healing. Nature Communications. 15(1). 739–739. 46 indexed citations breakdown →
7.
Wang, Siyu, Yuebao Zhang, Yichen Zhong, et al.. (2024). Accelerating diabetic wound healing by ROS-scavenging lipid nanoparticle–mRNA formulation. Proceedings of the National Academy of Sciences. 121(22). e2322935121–e2322935121. 30 indexed citations
8.
Yan, Jinyue, Diana D. Kang, Chang Wang, et al.. (2024). LPA1 antagonist-derived LNPs deliver A20 mRNA and promote anti-fibrotic activities. Nano Research. 17(10). 9095–9102. 1 indexed citations
9.
Zhang, Yuebao, Xucheng Hou, Shi Du, et al.. (2023). Close the cancer–immunity cycle by integrating lipid nanoparticle–mRNA formulations and dendritic cell therapy. Nature Nanotechnology. 18(11). 1364–1374. 66 indexed citations
10.
Du, Shi, et al.. (2023). Adoptive cell therapy for cancer treatment. SHILAP Revista de lepidopterología. 3(4). 20210058–20210058. 62 indexed citations
11.
Zhong, Yichen, Shi Du, & Yizhou Dong. (2023). mRNA delivery in cancer immunotherapy. Acta Pharmaceutica Sinica B. 13(4). 1348–1357. 31 indexed citations
12.
Zhang, Yuebao, Jinyue Yan, Xucheng Hou, et al.. (2023). STING Agonist-Derived LNP-mRNA Vaccine Enhances Protective Immunity Against SARS-CoV-2. Nano Letters. 23(7). 2593–2600. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026